According to Xinhua Media's announcement, the cumulative deviation value of the company's stock closing price increase exceeded 20% for three consecutive trading days on September 21, September 22, and September 23, 2026, which is an abnormal fluctuation in stock trading. The company currently has normal production and operation, and the main business has not changed. The deducted non-net profit for 2025 is -16.2975 million yuan. The company previously disclosed that it plans to issue shares to purchase 100% of the shares of Shanghai Interface Finance Association Technology Co., Ltd. This transaction constitutes a major asset restructuring and related transaction. Currently, audits, evaluations, etc. have not been completed, and internal decision-making procedures and regulatory approval are still required. There is uncertainty about whether and when it will be approved. Other than the above matters, the company and controlling shareholders have no other important matters that should be disclosed, and the controlling shareholders, directors, and supervisors did not trade the company's shares during the change period.

According to Xinhua Media's announcement, the cumulative deviation value of the company's stock closing price increase exceeded 20% for three consecutive trading days on September 21, September 22, and September 23, 2026, which is an abnormal fluctuation in stock trading. The company currently has normal production and operation, and the main business has not changed. The deducted non-net profit for 2025 is -16.2975 million yuan. The company previously disclosed that it plans to issue shares to purchase 100% of the shares of Shanghai Interface Finance Association Technology Co., Ltd. This transaction constitutes a major asset restructuring and related transaction. Currently, audits, evaluations, etc. have not been completed, and internal decision-making procedures and regulatory approval are still required. There is uncertainty about whether and when it will be approved. Other than the above matters, the company and controlling shareholders have no other important matters that should be disclosed, and the controlling shareholders, directors, and supervisors did not trade the company's shares during the change period.